These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20225662)

  • 1. Evaluation of blockbuster drugs under the rule-of-five.
    Giménez BG; Santos MS; Ferrarini M; Fernandes JP
    Pharmazie; 2010 Feb; 65(2):148-52. PubMed ID: 20225662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selecting the right compounds for screening: does Lipinski's Rule of 5 for pharmaceuticals apply to agrochemicals?
    Tice CM
    Pest Manag Sci; 2001 Jan; 57(1):3-16. PubMed ID: 11455629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADME evaluation in drug discovery. 7. Prediction of oral absorption by correlation and classification.
    Hou T; Wang J; Zhang W; Xu X
    J Chem Inf Model; 2007; 47(1):208-18. PubMed ID: 17238266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative strategies in drug development: clinical pharmacological aspects.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pursuing the leadlikeness concept in pharmaceutical research.
    Hann MM; Oprea TI
    Curr Opin Chem Biol; 2004 Jun; 8(3):255-63. PubMed ID: 15183323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of high throughput technology for the screening of natural products.
    Mishra KP; Ganju L; Sairam M; Banerjee PK; Sawhney RC
    Biomed Pharmacother; 2008 Feb; 62(2):94-8. PubMed ID: 17692498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ask the experts: past, present and future of the rule of five.
    Baell J; Congreve M; Leeson P; Abad-Zapatero C
    Future Med Chem; 2013 May; 5(7):745-52. PubMed ID: 23651089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection criteria for drug-like compounds.
    Muegge I
    Med Res Rev; 2003 May; 23(3):302-21. PubMed ID: 12647312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of data fusion methods in virtual screening: theoretical model.
    Whittle M; Gillet VJ; Willett P; Loesel J
    J Chem Inf Model; 2006; 46(6):2193-205. PubMed ID: 17125164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for low aquatic bioaccumulation. 1. Lipinski's 'Rule of 5' and molecular size.
    Nendza M; Müller M
    SAR QSAR Environ Res; 2010 Jul; 21(5-6):495-512. PubMed ID: 20818584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating cheminformatic analysis in combinatorial chemistry.
    Blake JF
    Curr Opin Chem Biol; 2004 Aug; 8(4):407-11. PubMed ID: 15288251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput characterization and quality control of small-molecule combinatorial libraries.
    Kenseth JR; Coldiron SJ
    Curr Opin Chem Biol; 2004 Aug; 8(4):418-23. PubMed ID: 15288253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug- and lead-likeness, target class, and molecular diversity analysis of 7.9 million commercially available organic compounds provided by 29 suppliers.
    Chuprina A; Lukin O; Demoiseaux R; Buzko A; Shivanyuk A
    J Chem Inf Model; 2010 Apr; 50(4):470-9. PubMed ID: 20297844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug and drug candidate building block analysis.
    Wang J; Hou T
    J Chem Inf Model; 2010 Jan; 50(1):55-67. PubMed ID: 20020714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico fragment screening by replica generation (FSRG) method for fragment-based drug design.
    Fukunishi Y; Mashimo T; Orita M; Ohno K; Nakamura H
    J Chem Inf Model; 2009 Apr; 49(4):925-33. PubMed ID: 19354203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug discovery beyond the 'rule-of-five'.
    Zhang MQ; Wilkinson B
    Curr Opin Biotechnol; 2007 Dec; 18(6):478-88. PubMed ID: 18035532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image-based chemical screening.
    Carpenter AE
    Nat Chem Biol; 2007 Aug; 3(8):461-5. PubMed ID: 17637778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological activity predictions, crystallographic comparison and hydrogen bonding analysis of cholane derivatives.
    Rajnikant ; Dinesh ; Chand B
    Indian J Biochem Biophys; 2007 Dec; 44(6):458-69. PubMed ID: 18320845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of natural products upon modern drug discovery.
    Ganesan A
    Curr Opin Chem Biol; 2008 Jun; 12(3):306-17. PubMed ID: 18423384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry.
    Feher M; Schmidt JM
    J Chem Inf Comput Sci; 2003; 43(1):218-27. PubMed ID: 12546556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.